Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome.
about
Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and TargetsFOXP3: genetic and epigenetic implications for autoimmunityRegulatory T-cells: diverse phenotypes integral to immune homeostasis and suppressionAbsence of leucine zipper in the natural FOXP3Delta2Delta7 isoform does not affect dimerization but abrogates suppressive capacity.IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF).Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation.Programmed cell death-10 enhances proliferation and protects malignant T cells from apoptosis.Signalling through FOXP3 as an X-linked tumor suppressor.The histone deacetylase inhibitors vorinostat and romidepsin downmodulate IL-10 expression in cutaneous T-cell lymphoma cells.Dissecting the role of the FOXP3 gene in the joint genetic susceptibility to autoimmune thyroiditis and diabetes: a genetic and functional analysisInactivation of X-linked tumor suppressor genes in human cancer.FOXP3 as an X-linked tumor suppressor.The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma.TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma.Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma.Elucidating the role of interleukin-17F in cutaneous T-cell lymphomaEctopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.Induced Sézary syndrome PBMCs poorly express immune response genes up-regulated in stimulated memory T cellsMalignant inflammation in cutaneous T-cell lymphoma-a hostile takeoverRegulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome.Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management.The four types of Tregs in malignant lymphomas.The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma.Tissue-specific homing of immune cells in malignant skin tumors.The role of FOXP3 in regulating immune responses.miRNA in mycosis fungoides and skin inflammation.Peripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications.Sézary syndrome: old enigmas, new targets.New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis.Sézary Syndrome: Clinical and Biological Aspects.Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphomaBortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells.Vascular endothelial growth factor receptor-3 expression in mycosis fungoides.Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force StudAltered balance between self-reactive T helper (Th)17 cells and Th10 cells and between full-length forkhead box protein 3 (FoxP3) and FoxP3 splice variants in Hashimoto's thyroiditis.Blood flow cytometry in Sézary syndrome: new insights on prognostic relevance and immunophenotypic changes during follow-up.Regulation gone wrong: a subset of Sézary patients have malignant regulatory T cells.Expression of miR-155 and miR-126 in situ in cutaneous T-cell lymphoma.Functional characterization of Foxp3-specific spontaneous immune responses.The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part II: The Treg role in skin diseases pathogenesis.
P2860
Q26746551-58AE3C6E-3243-43A9-9385-5C2663AFC16AQ27003398-E8F8BD62-0B2E-44E5-A75A-CD480AF14563Q27022973-92A2736A-C74F-4D5C-A06A-C58B86C9844CQ33476832-7B201B0E-2536-4198-9DDE-AA8366EE0113Q33728396-ACA9EA57-50E4-4C35-B628-FAC670C71227Q33987080-7CEDF117-F029-4427-BC64-56061EF7D0A0Q34154516-85662E77-E1C6-4732-B3F2-84E91311B847Q34176581-0C6B91BE-4622-4FBA-A5AD-0E135F4CA4A5Q34672100-A1A6A0DF-2F19-473C-B092-7A2407928BA6Q34778974-B4A35C93-3AA7-48EE-A6C9-EF799A2A27B0Q35206452-1018C19C-FC3B-4E2E-A8A2-67AB1FFD2A6BQ35845395-10986D2C-59A6-4DB8-B592-186439364401Q35858578-78A37331-44FA-4DFA-B0C3-95BD08A993D9Q37025122-66655324-C477-42D6-991A-16828C6D9831Q37139517-348B1F8B-2AD2-4462-9C4C-9E7B95D1E704Q37216178-C8C85E7D-5BED-45E3-93CD-A4248349511FQ37237464-C24239D7-1C3E-4BD0-9DA1-A07E4987C3C6Q37591359-9D8D3581-D10D-431C-87A5-2539A024707BQ37723390-2E5A81FD-1CA5-44D6-AD16-65B1AC44B050Q37929548-101047AE-0014-42CB-8103-45106E213885Q37944565-ABDC43B6-84E7-4F08-BF26-6B3EEF9F5304Q37966000-C512FBD9-A86C-447A-9A18-1E4C7DB17601Q37975058-77FFE452-6AF0-4D75-8DEB-7A528AE9F9EBQ38005015-14457934-58F2-41A6-96F2-390A32CAD3F8Q38129079-CFBB0F5D-8DF3-4216-8FBA-43640849A0EBQ38150868-FB9CE192-BD12-459A-B202-3D0C263B0472Q38289038-12AA2081-EAA7-4C70-961D-79F1711FD91EQ38772711-20C8D20A-052C-4779-BB01-49F203A9DD27Q38799600-2ED32913-F834-41B1-B2F2-557FE8DABE69Q38814744-9FBF700E-D902-4784-A42C-FB43F4CCC41FQ38846167-5E07D64C-39D1-453C-BBA0-668880857AA0Q38909786-312C9A1A-0479-4FC2-870C-CD3833BCD3A4Q39285766-0CED6050-E13B-450A-8081-2F80163FC9C7Q41086530-BA69E612-BB4B-4E84-A298-6762C3D9FF85Q41654435-C972FEF7-CCFA-4AD4-AA4E-FEDF0CD6B087Q41686065-3039E20D-CECE-4A62-9209-F85C82A4CB61Q41849574-A194C524-3FC2-4478-89B0-F551896A27B1Q44374191-0F759DA1-27F8-4F63-886D-F31E3AACD71FQ50868528-669750C3-367E-439D-827D-A044E13BB64CQ54261770-9950D62C-BE44-42F7-AA3E-07EAB1C55A3A
P2860
Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome.
@en
Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome.
@nl
type
label
Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome.
@en
Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome.
@nl
prefLabel
Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome.
@en
Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome.
@nl
P2093
P2860
P50
P356
P1433
P1476
Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome
@en
P2093
A-M Mathiesen
B Lauenborg
E Ralfkiaer
K W Eriksen
L M Gjerdrum
P2860
P2888
P304
P356
10.1038/LEU.2008.224
P577
2008-09-04T00:00:00Z